Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

NCT02828462 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Cancer
Hematological Malignancy

Interventions

OTHER: CAPRI

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris